ACE Inhibitor Side Effects: Common, Serious & Long-Term
ACE inhibitors like lisinopril and ramipril most commonly cause a persistent dry cough due to bradykinin accumulation, affecting 10-15% of patients, with rare but potentially fatal angioedema being the most critical serious risk. These medications are absolutely contraindicated in pregnancy due to documented fetal toxicity, and potassium levels and kidney function require regular monitoring.
Overview
ACE inhibitors (angiotensin-converting enzyme inhibitors) are cornerstone medications for hypertension, heart failure, chronic kidney disease, and cardiovascular risk reduction after heart attack. Lisinopril is one of the most prescribed medications in the United States; ramipril is widely used for cardioprotection. As a class, ACE inhibitors are generally well tolerated and have a favorable long-term safety profile — but several side effects are class-specific and clinically important to recognize.
ACE inhibitors block the conversion of angiotensin I to angiotensin II — a potent vasoconstrictor — thereby lowering blood pressure and reducing strain on the heart and kidneys. This same mechanism also prevents the breakdown of bradykinin, a peptide whose accumulation is responsible for the most common and most serious ACE inhibitor side effects.
Common Side Effects
Mechanism
The majority of ACE inhibitor side effects arise from two distinct pathways: angiotensin II reduction (which lowers blood pressure and reduces kidney filtration pressure) and bradykinin accumulation (which irritates sensory nerves and promotes vascular permeability).
- Dry cough — the most common side effect of the entire class; a persistent, tickling, non-productive cough caused by bradykinin accumulation in the airways; affects approximately 10-15% of patients; more common in women and patients of East Asian descent; the cough resolves after stopping the medication
- Dizziness and lightheadedness — particularly with the first dose or dose increases; caused by blood pressure reduction; most pronounced when standing up quickly (orthostatic hypotension)
- Hyperkalemia (high potassium) — ACE inhibitors reduce aldosterone levels, which normally causes potassium excretion; potassium can accumulate, especially in patients with kidney impairment or those taking potassium supplements or potassium-sparing diuretics
- Fatigue — a general sense of low energy reported by some patients, often transient
- Taste disturbance — a metallic or altered taste (dysgeusia) can occur, particularly with captopril
- Rash — skin rashes occur in a small percentage of patients, most commonly with captopril
Serious Side Effects
⚠ Angioedema involving the throat or tongue is a medical emergency — call 911 immediately. Any episode of angioedema on an ACE inhibitor is an absolute contraindication to all future ACE inhibitor use.
Angioedema
Angioedema is the most feared serious adverse effect of ACE inhibitors. It involves rapid, deep tissue swelling — most dangerously of the lips, tongue, throat, and larynx — and can obstruct breathing within minutes. It is caused by uncontrolled bradykinin accumulation leading to increased vascular permeability. While it affects only a small percentage of patients (approximately 0.1-0.7%), it can occur at any time — even in patients who have taken the medication for years without problems. Angioedema caused by ACE inhibitors does not respond well to antihistamines or epinephrine (unlike allergic angioedema), and emergency airway management may be required.
First-Dose Hypotension
A significant drop in blood pressure can occur after the first dose, particularly in patients who are volume-depleted (from diuretics or low salt intake), or in those with heart failure. This can cause fainting or falls. The first dose is typically taken at bedtime to minimize this risk, and patients with heart failure often begin with very low starting amounts.
Acute Kidney Injury
ACE inhibitors reduce the efferent arteriolar pressure in the kidneys, which is the mechanism behind their renal protection in diabetic nephropathy. However, in patients with bilateral renal artery stenosis, or in those who are volume-depleted or on NSAIDs, this same effect can precipitate acute kidney injury. Creatinine and potassium levels should be checked within 1-2 weeks of starting or changing the dose.
Long-Term Effects
ACE inhibitors are among the best-tolerated long-term cardiovascular medications. When they are well tolerated, their long-term safety profile is favorable:
- Kidney function monitoring — regular checks of creatinine and potassium are important; a modest rise in creatinine (up to 30% above baseline) is expected and generally acceptable, reflecting the intended reduction in glomerular filtration pressure
- Potassium monitoring — particularly important for patients also taking potassium-sparing diuretics (spironolactone, eplerenone), NSAIDs, or those with diabetes
- Cardiovascular protection — long-term ACE inhibitor use is associated with reduced risk of heart attack, stroke, and progression of kidney disease in high-risk patients; these benefits compound over years
- No significant metabolic burden — unlike some antihypertensives, ACE inhibitors do not adversely affect blood glucose, lipids, or weight
Who Is Most at Risk
- Pregnant women — absolutely contraindicated; can cause severe fetal harm (see black box warning below)
- Patients with bilateral renal artery stenosis — risk of acute kidney injury; ACE inhibitors are generally contraindicated
- Those with elevated baseline potassium — or on concurrent potassium-raising medications; risk of dangerous hyperkalemia
- Volume-depleted patients — on high-dose diuretics or low-sodium diets; heightened risk of first-dose hypotension and kidney injury
- Prior angioedema history — any history of ACE inhibitor-induced angioedema is an absolute contraindication to the entire class
ACE inhibitors can cause fetal injury and death when administered to pregnant women. When pregnancy is detected, ACE inhibitors should be discontinued as soon as possible. Drugs that act directly on the renin-angiotensin system can cause fetal renal dysplasia, oligohydramnios, limb contractures, craniofacial deformities, and neonatal death, particularly when used during the second and third trimesters.
Managing Side Effects
- Persistent dry cough — the cough is a class effect; switching to an ARB (angiotensin receptor blocker) such as losartan or valsartan provides equivalent blood pressure lowering without bradykinin accumulation and eliminates the cough
- First-dose dizziness — take the first dose at bedtime; rise slowly from sitting or lying positions; ensure adequate hydration
- Hyperkalemia — avoid potassium supplements and salt substitutes (which contain potassium); review concurrent medications; dietary potassium may need to be monitored in high-risk patients
- Rising creatinine — a modest rise is expected and acceptable; your prescriber will advise if levels require dose adjustment or medication change
- Any swelling of the face, lips, or throat — treat as a medical emergency; call 911; do not take another dose
Frequently Asked Questions
Why do ACE inhibitors cause a dry cough?
ACE inhibitors block the angiotensin-converting enzyme, which is also responsible for breaking down bradykinin. As bradykinin accumulates in the lungs and airways, it irritates sensory nerves and causes a persistent dry, tickling cough. This affects approximately 10-15% of patients and is more common in women and people of Asian descent. The cough resolves after stopping the medication.
What is angioedema and how dangerous is it with ACE inhibitors?
Angioedema is rapid swelling of the deep layers of skin, most dangerously affecting the throat, tongue, lips, and face. When it occurs with ACE inhibitors — typically due to bradykinin accumulation — it can obstruct the airway and be life-threatening. Any patient who develops angioedema on an ACE inhibitor must stop the medication immediately and seek emergency care. A history of ACE inhibitor-induced angioedema is an absolute contraindication to all ACE inhibitors.
Can I take an ACE inhibitor if I am pregnant?
No. ACE inhibitors carry an FDA black box warning for use during pregnancy. They are fetotoxic — particularly during the second and third trimesters — and can cause fetal renal damage, oligohydramnios, limb contractures, craniofacial deformities, and fetal death. ACE inhibitors must be discontinued as soon as pregnancy is detected.
What is the difference between an ACE inhibitor and an ARB?
ACE inhibitors (like lisinopril) block the enzyme that produces angiotensin II, while angiotensin receptor blockers (ARBs, like losartan) block the receptor that angiotensin II acts on. Both classes lower blood pressure similarly, but ARBs do not cause bradykinin accumulation and therefore do not cause the ACE inhibitor cough. ARBs are commonly used as an alternative for patients who develop the cough. Patients who have had angioedema with an ACE inhibitor should discuss carefully with their prescriber before switching to an ARB, as cross-reactivity is possible.
Related Drugs
⚠ This article is for informational purposes only and does not constitute medical advice. ACE inhibitor decisions — including starting, stopping, or switching to an ARB — should always be made in consultation with your prescriber.